Dendrobium officinale polysaccharide inhibits vascular calcification via anti‐inflammatory and anti‐apoptotic effects in chronic kidney disease. Issue 9 (18th August 2022)

• Record Type: Journal Article
• Authors: Jiang, Wangsheng; Ruan, Wenfeng; Wang, Zhengqiang
• Is Part Of: FASEB journal. Volume 36:Issue 9(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-08-18
• Subjects: apoptosis -- cardiovascular disease -- heme oxygenase‐1 -- inflammation effect -- rats -- vascular smooth muscle cells; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202200353RRR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Vascular calcification is very common in patients with chronic kidney disease (CKD), but so far, there is no effective treatment. Dendrobium officinale polysaccharide (DOP), a natural component of Chinese herbal medicine, has been shown to exert anti‐inflammatory and anti‐apoptotic activity. Inflammation and apoptosis play an essential role in the progression of vascular calcification. However, the exact role and molecular mechanisms of DOP in vascular calcification remain unclear. In this study, we investigated the effects of DOP on vascular calcification using vascular smooth muscle cells (VSMCs), arterial rings, and CKD rats. Alizarin red staining and gene expression analysis revealed that DOP inhibited calcification and osteogenic differentiation of rat VSMCs in a dose‐dependent manner. Similarly, ex vivo studies revealed that DOP inhibited the calcification of rat arterial rings. Furthermore, the administration of DOP alleviated vascular calcification in CKD rats. Moreover, DOP treatment suppressed VSMC inflammation and apoptosis. Finally, DOP treatment upregulated mRNA and protein levels of heme oxygenase‐1 (HMOX‐1); both pharmacological inhibition of HMOX‐1 by the HMOX‐1 inhibitor zinc protoporphyrin‐9ZnPP9 and knockdown of HMOX‐1 by siRNA markedly abrogated the suppression of inflammation and osteogenic differentiation of VSMCs by DOP. Collectively, these results suggest that DOP alleviates vascular calcification in CKD by suppressing apoptosis and inflammation via HMOX‐1 activation. These results may provide a promising treatment for vascular calcification in CKD.